Gene · 7170
Papers3,595
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,595
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Computational study of the structural ensemble of CC chemokine receptor type 5 (CCR5) and its interactions with different ligands. | PLoS One | 2022 | 36251708 | PubTator, text mining | PubMed |
| USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma. | Oncogene | 2022 | 36243803 | PubTator, text mining | PubMed |
| Cryo-EM structure of the human NKCC1 transporter reveals mechanisms of ion coupling and specificity. | EMBO J | 2022 | 36239040 | PubTator, text mining | PubMed |
| A recurrent inflammatory myofibroblastic tumor patient with two novel ALK fusions: a case report. | Transl Cancer Res | 2022 | 36237256 | PubTator, text mining | PubMed |
| Nemaline Myopathy in Brazilian Patients: Molecular and Clinical Characterization. | Int J Mol Sci | 2022 | 36233295 | PubTator, text mining | PubMed |
| MEG3 Expression Indicates Lymph Node Metastasis and Presence of Cancer-Associated Fibroblasts in Papillary Thyroid Cancer. | Cells | 2022 | 36231143 | PubTator, text mining | PubMed |
| Molecular targeted therapy for anticancer treatment. | Exp Mol Med | 2022 | 36224343 | PubTator, text mining | PubMed |
| A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers-Analytical validation and performance evaluation with clinical samples. | Front Mol Biosci | 2022 | 36213130 | PubTator, text mining | PubMed |
| Inflammatory Myofibroblastic Tumor of the Hilar Bile Duct: A Case Report and Literature Review. | Front Surg | 2022 | 36211291 | PubTator, text mining | PubMed |
| A computational study of the structure and function of human Zrt and Irt-like proteins metal transporters: An elevator-type transport mechanism predicted by AlphaFold2. | Front Chem | 2022 | 36204150 | PubTator, text mining | PubMed |
| Targeted transcript analysis in muscles from patients with genetically diverse congenital myopathies. | Brain Commun | 2022 | 36196089 | PubTator, text mining | PubMed |
| Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'. | Eur J Cancer | 2022 | 36182817 | PubTator, text mining | PubMed |
| Pharmacological targeting of G protein-coupled receptor heteromers. | Pharmacol Res | 2022 | 36182040 | PubTator, text mining | PubMed |
| OPRM1-ROS1 Fusion Detected by Next-Generation Sequencing with Circulating DNA in a Patient with EGFR Mutated Advanced NSCLC: A Case Report. | Case Rep Oncol | 2022 | 36157687 | PubTator, text mining | PubMed |
| Weak Cation Selectivity in HCN Channels Results From K+-Mediated Release of Na+ From Selectivity Filter Binding Sites. | Function (Oxf) | 2022 | 36156894 | PubTator, text mining | PubMed |
| Genetics, Functions, and Clinical Impact of Presenilin-1 (PSEN1) Gene. | Int J Mol Sci | 2022 | 36142879 | PubTator, text mining | PubMed |
| Recent Advances in PROTACs for Drug Targeted Protein Research. | Int J Mol Sci | 2022 | 36142231 | PubTator, text mining | PubMed |
| Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung Cancer. | Cells | 2022 | 36139444 | PubTator, text mining | PubMed |
| Clinical Characterization and Prognostic Value of TPM4 and Its Correlation with Epithelial-Mesenchymal Transition in Glioma. | Brain Sci | 2022 | 36138856 | PubTator, text mining | PubMed |
| Stress deprivation of tendon explants or Tpm3.1 inhibition in tendon cells reduces F-actin to promote a tendinosis-like phenotype. | Mol Biol Cell | 2022 | 36129771 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7170/papers?page=30